Compare Lustrum:CellSource Co., Ltd.:4880

※The values of financial statements might be different from the actual ones. Please confirm the original. [instructions]

Main FunctionHelp Company NameHelp CodeHelp Types of IndustryHelp Market Name Fiscal Year End Year of Listing
Browse U-Chart Add to 'Companies Comparison' list Compare Lustrum Ullet index CellSource Co., Ltd. 4880 Medicals 東証プライム October 1, 2000 2019.
Analysis u.gifU-Chart AnalysisHelp hikaku.gifAdd to 'Companies Comparison' listHelp u2.gifCompare LustrumHelp mark.gifUllet indexHelp
Accounts Information Balance Sheet Profit and Loss Account Cash Flow Statement
Display

CellSource Co., Ltd. Balance Sheet(B/S)

[Show - Hide] U-Chart:Balance Sheet (B/S)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

CellSource Co., Ltd. Balance Sheet 2023年10月期 CellSource Co., Ltd. Balance Sheet 2022年10月期 CellSource Co., Ltd. Balance Sheet 2021年10月期 CellSource Co., Ltd. Balance Sheet 2020年10月期 CellSource Co., Ltd. Balance Sheet 2019年10月期

[Show - Hide] Balance Sheet (B/S)Help  ※Unit:Millions of Yen

Accounting Date October 31, 2023 October 31, 2022 October 31, 2021 October 31, 2020 October 31, 2019
Cash and Cash Equivalents
(Percent)
4,781up
(69.5%)up
3,124up
(67.9%)down
2,409up
(71.6%)down
1,757up
(74.7%)up
1,334
(72.4%)
Other Current AssetsHelp
(Percent)
808down
(11.7%)down
954up
(20.7%)up
537up
(15.9%)down
409up
(17.4%)down
321
(17.4%)
Tangible Fixed AssetsHelp
(Percent)
659up
(9.6%)up
166up
(3.6%)up
110up
(3.3%)down
83up
(3.5%)down
73
(4.0%)
Intangible Fixed AssetHelp
(Percent)
20up
(0.3%)up
10down
(0.2%)down
11
(0.3%)down
11up
(0.5%)up
5
(0.3%)
Investments and OthersHelp
(Percent)
612up
(8.9%)up
346up
(7.5%)down
298up
(8.9%)up
92down
(3.9%)down
109
(5.9%)
Total AssetsHelp
(Percent)
6,880
(100%)
4,600
(100%)
3,365
(100%)
2,352
(100%)
1,842
(100%)
Total Current LiabilitiesHelp
(Percent)
600down
(8.7%)down
814up
(17.7%)down
645up
(19.2%)up
309up
(13.1%)up
230
(12.5%)
Total Long-term LiabilitiesHelp
(Percent)
77
(1.1%)
0
-
0
-
1down
(0.0%)down
4
(0.2%)
Shareholder's EquityHelp
(Percent)
6,202up
(90.1%)up
3,786up
(82.3%)up
2,720up
(80.8%)down
2,043up
(86.8%)down
1,608
(87.3%)
Total LiabilitiesHelp
(Percent)
6,880
(100%)
4,600
(100%)
3,365
(100%)
2,352
(100%)
1,842
(100%)

CellSource Co., Ltd. Profit and Loss Account(P/L)

[表示非表示] U-Chart:Profit and Loss Account (P/L)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

CellSource Co., Ltd. Profit and Loss Account 2023年10月期 CellSource Co., Ltd. Profit and Loss Account 2022年10月期 CellSource Co., Ltd. Profit and Loss Account 2021年10月期 CellSource Co., Ltd. Profit and Loss Account 2020年10月期 CellSource Co., Ltd. Profit and Loss Account 2019年10月期

[Show - Hide] Profit and Loss Account (P/L)Help  ※Unit:Millions of Yen

Accounting Date October 31, 2023 October 31, 2022 October 31, 2021 October 31, 2020 October 31, 2019
Amount of Sales
(Percent)
4,511
(100%)
4,274
(100%)
2,922
(100%)
1,855
(100%)
1,612
(100%)
Total Sales
(Percent)
4,511
(100%)
4,274
(100%)
2,922
(100%)
1,855
(100%)
1,612
(100%)
Cost of SalesHelp
(Percent)
1,326up
(29.4%)up
1,210up
(28.3%)down
848up
(29.0%)down
597up
(32.1%)up
458
(28.4%)
Other Costs and RevenueHelp 2,262up
(50.1%)up
2,046up
(47.9%)down
1,423up
(48.7%)down
985up
(53.1%)down
954
(59.2%)
Total CostsHelp 3,587 3,256 2,271 1,581 1,412
Net RevenueHelp 3,185up
(70.6%)down
3,064up
(71.7%)up
2,074up
(71.0%)up
1,259up
(67.9%)down
1,154
(71.6%)
Earnings Before TaxHelp 1,240down
(27.5%)down
1,584up
(37.1%)up
1,006up
(34.4%)up
413up
(22.2%)up
303
(18.8%)
Net IncomeHelp 923down
(20.5%)down
1,018up
(23.8%)up
651up
(22.3%)up
274up
(14.8%)up
200
(12.4%)
当期純利益 923 1,018 651 274 200

CellSource Co., Ltd. Cash Flow Statement(C/F)

[表示非表示] U-Chart:Cash Flow Statement (C/F)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

CellSource Co., Ltd. Cash Flow Statement 2023年10月期 CellSource Co., Ltd. Cash Flow Statement 2022年10月期 CellSource Co., Ltd. Cash Flow Statement 2021年10月期 CellSource Co., Ltd. Cash Flow Statement 2020年10月期 CellSource Co., Ltd. Cash Flow Statement 2019年10月期

[Show - Hide] Cash Flow Statement (C/F)Help  ※Unit:Millions of Yen

Accounting Date October 31, 2023 October 31, 2022 October 31, 2021 October 31, 2020 October 31, 2019
Operating Cash Flow(OFC)Help
(Percent)
847down
(36.9%)down
848down
(95.9%)down
898up
(98.9%)up
330up
(68.6%)up
195
(16.4%)
Investing Cash Flow(ICF)Help
(Percent)
-624down
(-27.2%)down
-169up
(-19.2%)up
-256down
(-28.2%)down
-58up
(-12.0%)down
-108
(-9.1%)
Financing Cash FlowHelp
(Percent)
1,449up
(63.1%)up
14up
(1.6%)up
9down
(1.0%)down
14up
(3.0%)up
9
(0.8%)
Exchange Difference of Cash and Cash EquivalentsHelp
(Percent)
-14down
(-0.6%)down
22up
(2.4%)up
1down
(0.1%)down
137down
(28.4%)down
984
(82.8%)
Net Increase and Decrease in Cash and Cash Equivalentsn 1,657up
(72.2%)down
714up
(80.8%)up
652up
(71.8%)down
423down
(88.0%)down
1,081
(90.9%)

他社比較Help

Companies in 'Companies Comparison' list

Browsing historyHelp

Your reecently viewed companies

CellSource Co., Ltd.

Company where related level is highHelp

Sumitomo Pharma Co., Ltd.
Renascience Inc.
CHUKYOIYAKUHIN CO.,LTD.
TAISHO PHARMACEUTICAL HOLDINGS CO., LTD.
SEIKAGAKU CORPORATION
SAWAI GROUP HOLDINGS Co., Ltd.
Chiome Bioscience Inc.
Mitsubishi Tanabe Pharma Corporation
Modalis Therapeutics Corporation
Cyfuse Biomedical K.K.